ERBB2 and cancer: STMN1 is a prognostic marker for various types of cancer, such as breast and endometrial cancer [19, 20], and has also been shown to be independent of other factors, such as age, menopausal status, nodal status, nuclear grade, tumor size, and ER, PR, and HER2 expression [21].